Safety, tolerability, pharmacokinetics, immunogenicity, and pharmacodynamics of MG-ZG122, a long-acting humanized anti-thymic stromal lymphopoietin mAb, in healthy Chinese: a randomized, double-blind, placebo-controlled, dose-escalation, phase I stud
Safety, tolerability, pharmacokinetics, immunogenicity, and pharmacodynamics of MG-ZG122, a long-acting humanized anti-thymic stromal lymphopoietin mAb, in healthy Chinese: a randomized, double-blind, placebo-controlled, dose-escalation, phase I stud
Jinlin Guo, Chenghai Zhang, Liang Zheng, Qiuling Zou et al.
Journal
Expert Opinion on Investigational Drugs
Topics
Allergic Rhinitis and Sensitization
article
Safety, tolerability, pharmacokinetics, immunogenicity, and pharmacodynamics of MG-ZG122, a long-acting humanized anti-thymic stromal lymphopoietin mAb, in healthy Chinese: a randomized, double-blind, placebo-controlled, dose-escalation, phase I stud
Jinlin Guo, Chenghai Zhang, Liang Zheng, Qiuling Zou, Dong Qin, Lingqiao Zhu, Xuan Zhang, Qian Zhang, Wei Hu, Rui Yan
article en
Abstract
No abstract available for this paper.
Publication Tag
Expert Opinion on Investigational DrugsVol. 34(11)
Institutions
Anhui Medical University (CN), Second Affiliated Hospital of Anhui Medical University (CN)